SCHEMBL27157385

SCHEMBL27157385

Cc1nnc(C2CCCN(C(=O)OC(C)(C)C)C2)s1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GLS O94925 2/20 0.46
JAK2 O60674 1/20 0.45
JAK1 P23458 1/20 0.45
ALDH1A1 P00352 2/20 0.44
MAPT P10636 2/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
HPGDS O60760 1/20 0.43
HPGD P15428 2/20 0.42
KDM4E B2RXH2 2/20 0.40
ACKR3 P25106 1/20 0.40
GLA P06280 1/20 0.40
RECQL P46063 1/20 0.40
HSD17B10 Q99714 1/20 0.40
TRPV3 Q8NET8 1/20 0.40
USP30 Q70CQ3 1/20 0.39
P2RX7 Q99572 1/20 0.39
BACE1 P56817 2/20 0.38
CTSD P07339 1/20 0.38
PDE4B Q07343 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23791309 0.94 MAPT (0.43) GLSALDH1A1MAPTMEN1KMT2A
SCHEMBL31169229 0.86 THRB (0.48) GLSJAK2JAK1MAPTKMT2A
SCHEMBL27157327 0.81 HPGDS (0.54) JAK2JAK1HPGDSACKR3USP30
SCHEMBL17069033 0.80 ALDH1A1 (0.49) ALDH1A1MAPTMEN1KMT2AHSD17B10
SCHEMBL663645 0.79 DPP4 (0.45) GLSJAK2JAK1ALDH1A1MAPT
SCHEMBL21858824 0.79 GLS (0.43) GLSJAK2JAK1ALDH1A1MAPT
SCHEMBL27157390 0.78 TRPV3 (0.46) GLSJAK2JAK1ALDH1A1MAPT
SCHEMBL27157339 0.78 P2RX7 (0.48) GLSJAK2JAK1HPGDSACKR3
SCHEMBL19544898 0.77 HPGDS (0.47) GLSJAK2JAK1ALDH1A1MAPT
SCHEMBL3545981 0.77 HPGDS (0.47) GLSJAK2JAK1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240246952-A1 SMALL MOLECULE MODULATORS OF GLUCOCEREBROSIDASE ACTIVITY AND USES THEREOF VANQUA BIO, INC. (US) 2024-07-25 US disclosed
CN-117751114-A Small molecule modulators of glucocerebrosidase activity and uses thereof 凡况生化公司 2024-03-22 CN disclosed
EP-4329880-A1 SMALL MOLECULE MODULATORS OF GLUCOCEREBROSIDASE ACTIVITY AND USES THEREOF Vanqua Bio, Inc. (US) 2024-03-06 EP disclosed
WO-2022232360-A1 SMALL MOLECULE MODULATORS OF GLUCOCEREBROSIDASE ACTIVITY AND USES THEREOF VANQUA BIO, INC. (US) 2022-11-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240246952-A1 SMALL MOLECULE MODULATORS OF GLUCOCEREBROSIDASE ACTIVITY AND USES THEREOF GBA1, GAA, GBA2 GLS 259/4885JAK2 3271/4885JAK1 4241/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.